Related Experiment Video
Updated: Jun 20, 2026

Detection and Isolation of Campylobacter spp. from Raw Meat
Published on: February 23, 2024
Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection
Y A Rajabally1, A Ramlackhansingh, M Fraser
1Department of Neurology, Neuromuscular Clinic, Leicester General Hospital, University Hospitals of Leicester, Leicester LE5 4PW, United Kingdom. yusuf.rajabally@uhl-tr.nhs.uk
Abstract:
We report the case of a patient with Parkinson's disease who developed rapidly progressive weakness of the four limbs due to an acute motor axonal neuropathy (AMAN). This occurred days after a neuroleptic malignant syndrome (NMS). Serologic evidence of a preceding Campylobacter jejuni infection was detected and treatment with intravenous immunoglobulins proved effective. This case suggests that the rarely described neuropathies occurring with NMS may have a postinfectious immune basis and respond to immunomodulatory therapy.
Insights
A patient with Parkinson's disease developed acute motor axonal neuropathy (AMAN) after neuroleptic malignant syndrome (NMS). This post-infectious condition, linked to Campylobacter jejuni, responded well to immunoglobulin therapy.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Neuroleptic Malignant Syndrome (NMS) is a rare, life-threatening reaction to antipsychotic medications.
- Acute Motor Axonal Neuropathy (AMAN) is an autoimmune disorder affecting peripheral nerves.
- Parkinson's disease patients may have unique vulnerabilities to neurological complications.
Observation:
- A patient with Parkinson's disease experienced rapid limb weakness following NMS.
- The patient had serologic evidence of a preceding Campylobacter jejuni infection.
- Symptoms of AMAN appeared days after the NMS episode.
Findings:
- The co-occurrence of NMS and AMAN suggests a potential post-infectious immune-mediated process.
- Campylobacter jejuni infection is a known trigger for AMAN.
- Intravenous immunoglobulin therapy was effective in treating the neuropathy.
Implications:
- This case highlights a potential link between NMS, Campylobacter jejuni infection, and AMAN.
- Neuropathies associated with NMS may be immunologically mediated and treatable with immunomodulatory therapies.
- Further research is warranted to understand the pathogenesis and management of these rare neurological complications.
Related Concept Videos
Botulism
Bacterial Meningitis II: Pathophysiology
Bacterial Gastroenteritis
Tetanus
Bacterial Meningitis
Encephalitis ll: Pathophysiology
